Equitable Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Equitable Holdings's ARKG Position: Q2 2026 in Review
Equitable Holdings reduced its ARK Genomic Revolution ETF (ARKG) stake by 3.4% in Q2 2026, selling an estimated $46.6K and leaving 41,414 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #792.
Equitable Holdings first reported a position in ARKG in Q2 2020 and has held it in 16 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Equitable Holdings held 41,414 shares of ARK Genomic Revolution ETF worth $1.74M as of Q2 2026.
- Equitable Holdings sold 1,462 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $46.6K.
- ARK Genomic Revolution ETF made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #792 holding.
- Equitable Holdings first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 16 quarters since.
- 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.